Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enzo Biochem (DE:EZB)
:EZB
Holding DE:EZB?
Track your performance easily
EZB Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.66 - €1.31
Previous CloseN/A
Volume0.00
Average Volume (3M)17.00
Market Cap
€34.66M
Enterprise Value€15.61M
Total Cash (Recent Filing)$64.17M
Total Debt (Recent Filing)$573.00K
Price to Earnings (P/E)―
Beta-1.04
Next Earnings
Mar 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding52,244,076
10 Day Avg. Volume0
30 Day Avg. Volume17
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.17
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.45
Enterprise Value/Revenue0.52
Enterprise Value/Gross Profit1.07
Enterprise Value/Ebitda-2.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Enzo Biochem News
PremiumCompany Announcements
Enzo Biochem Reports Narrowed Loss Amid Revenue DeclinePremiumCompany Announcements
Enzo Biochem Appoints Jon Couchman to Board
PremiumCompany Announcements
Enzo Biochem Reports Revenue Growth Despite Losses
PremiumCompany Announcements
Enzo Biochem Board Member Resigns to Pursue New Opportunities
PremiumCompany Announcements
Enzo Biochem Enhances CFO Patricia Eckert’s Compensation Package
PremiumCompany Announcements
Enzo Biochem Executives Receive Raises and Equity RewardsPremiumCompany Announcements
Enzo Biochem Announces 2023 Annual Meeting OutcomesOptions Prices
Currently, No data available
---
Ownership Overview
10.86% Insiders
4.56% Mutual Funds
11.52% Other Institutional Investors
69.15% Public Companies and
Individual Investors
EZB FAQ
What was Enzo Biochem’s price range in the past 12 months?
Enzo Biochem lowest stock price was €0.66 and its highest was €1.31 in the past 12 months.
What is Enzo Biochem’s market cap?
Enzo Biochem’s market cap is €34.66M.
When is Enzo Biochem’s upcoming earnings report date?
Enzo Biochem’s upcoming earnings report date is Mar 17, 2025 which is in 61 days.
How were Enzo Biochem’s earnings last quarter?
Enzo Biochem released its earnings results on Dec 16, 2024. The company reported -€0.063 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.063.
Is Enzo Biochem overvalued?
According to Wall Street analysts Enzo Biochem’s price is currently Overvalued.
Does Enzo Biochem pay dividends?
Enzo Biochem pays a N/A dividend of €0.098 which represents an annual dividend yield of N/A. See more information on Enzo Biochem dividends here
What is Enzo Biochem’s EPS estimate?
Enzo Biochem’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enzo Biochem have?
Enzo Biochem has 52,244,076 shares outstanding.
What happened to Enzo Biochem’s price movement after its last earnings report?
Enzo Biochem reported an EPS of -€0.063 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.047%.
Which hedge fund is a major shareholder of Enzo Biochem?
Currently, no hedge funds are holding shares in DE:EZB
---
Enzo Biochem Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.63%
12-Months-Change
Fundamentals
Return on Equity
-11.83%
Trailing 12-Months
Asset Growth
-29.18%
Trailing 12-Months
Company Description
Enzo Biochem
Enzo Biochem, Inc. engages in the development, manufacture and sale of technology solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians globally. It operates through the following segments: Enzo Clinical Laboratory Services, Enzo Life Sciences Products, and Enzo Therapeutics. The Enzo Clinical Laboratory Services segment includes clinical reference laboratory providing a wide range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. The Enzo Life Sciences Products segment manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. The Enzo Therapeutics segment develops multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, many of which are derived from the pioneering work of Enzo Life Sciences. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.
---
EZB Earnings Call
Q1 2022
0:00 / 0:00
---
Technical Analysis
Enzo Biochem
―
ADMA Biologics
―
BioLife Solutions
―
Geron
―
PDS Biotechnology
―
Thermo Fisher
―
---